Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in-situ gel for periodontitis
NCT05583643Phase 1Completed
- Sponsor
- Misr University for Science and Technology
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of atorvastatin 1.2% gel in periodontitis, sponsored by Misr University for Science and Technology. Primary endpoints: Probing depth at 6 weeks and Bleeding index at 6 weeks. Started Dec 2021; status: completed.
02
Drugs
atorvastatin 1.2% gel
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05583643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583643.